Abstract:BACKGROUND:Understanding the mechanisms of drug resistance can facilitate better management of antiretroviral therapy, helping to prevent transmission and decrease the morbidity and mortality of people living with HIV/AIDS. However, there is little data about transmitted drug resistance and acquired drug resistance for HIV/AIDS patients in Shanghai.METHODS:A retrospective cohort study of HIV-infected patients who visited the Department of Infectious Disease from June 2008 to June 2015 was conducted in Shanghai, China. Logistic regression analysis was performed to analyze risk factors for drug resistance among HIV-infected people with virological failure. The related collected factors included patient age, gender, marital status, infection route, baseline CD4 count, antiretroviral therapy regimens, time between HIV diagnosis and initiating antiretroviral therapy. Factors with p<0.1 in the univariate logistic regression test were analyzed by multivariate logistic regression test.RESULTS:There were 575 subjects selected for this study and 369 participated in this research. For the antiretroviral therapy drugs, the rates of transmitted drug resistance and acquired drug resistance were significantly different. The non-nucleoside reverse transcriptase inhibitor (NNRTI) had the highest drug resistance rate (transmitted drug resistance, 10.9%; acquired drug resistance, 53.3%) and protease inhibitors (PIs) had the lowest drug resistance rate (transmitted drug resistance, 1.7%; acquired drug resistance, 2.7%). Logistic regression analysis found no factors that were related to drug resistance except marital status (married status for tenofovir: odds ratio = 6.345, 95% confidence interval = 1.553-25.921, P = 0.010) and the time span between HIV diagnosis and initiating antiretroviral therapy (≤6M for stavudine: odds ratio = 0.271, 95% confidence interval = 0.086-0.850, P = 0.025; ≤6M for didanosine: odds ratio = 0.284, 95% confidence interval = 0.096-0.842, P = 0.023; ≤6M for tenofovir: odds ratio = 0.079, 95% confidence interval = 0.018-0.350,P<0.001).CONCLUSION:NNRTI had a higher DR rate compared with nucleoside reverse transcriptase inhibitor (NRTI) and PIs, consequently, LPV/r was a reasonable choice for patients with NNRTI drugs resistance in China. Only married status and a time span≤6 month between the HIV confirmed date and the time initiating antiretroviral therapy were risk factors for TDF drug resistance. Both baseline HIV-RNA load and resistance test is crucial for TDR diagnosis, and frequent monitoring of HIV-RNA load is crucial for ADR identification and intervention. Treatment adherence still plays a positive role on the outcome of ART.

Antiretroviral Regimen Change among People Infected with HIV: Evidence from a Cross-Sectional Study in China

Hiv Drug Resistance And Its Impact On Antiretroviral Therapy In Chinese Hiv-Infected Patients

Incidence And Associated Factors Of Hiv Drug Resistance In Chinese Hiv-Infected Patients Receiving Antiretroviral Treatment

Successful Virologic Outcomes over Time among HAART-treated HIV-infected Patients.

Neuropsychiatric Adverse Events Following Antiretroviral Therapy in People Living with HIV: A Real-World Study of Dynamic Trends and Risk Factors in Hangzhou, China.

Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naïve Patients with HIV Infection: A Retrospective Cohort Analysis.

HIV Cause-Specific Deaths, Mortality, Risk Factors, and the Combined Influence of HAART and Late Diagnosis in Zhejiang, China, 2006–2013

An Analysis of Drug Resistance among People Living with HIV/AIDS in Shanghai, China

Changes in Clinical Indicators among Human Immunodeficiency Virus Patients Who Failed in Antiretroviral Therapy During 2004–2016 in Yunnan, China: an Observational Cohort Study

Changing Mortality and Patterns of Death Causes in HIV Infected Patients - China, 2013-2022

Treatment outcomes of initial differential antiretroviral regimens among HIV patients in Southwest China: comparison from an observational cohort study.

Treatment for HIV Prevention Study in Southwestern Areas of China.

Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy

Meta-analysis of adherence to highly active antiretroviral therapy in patients with HIV infection in China

Mortality Risk Factors Among People Living with HIV Receiving Second--line Antiretroviral Therapy in Rural China

Epidemiological and Mortality Analysis of Older Adults with Hiv in Eastern China

Factors Associated with Delayed and Late Initiation of Antiretroviral Therapy among Patients with HIV in Beijing, China, 2010–2020

Associations of Modern Initial Antiretroviral Therapy Regimens with All-Cause Mortality in People Living with HIV in Resource-Limited Settings: a Retrospective Multicenter Cohort Study in China

Time Between Diagnosis and Initiation of Antiretroviral Therapy among People Infected with HIV/AIDS from 2004 to 2016 in China: a Retrospective Database Study

Long-term effect of antiretroviral therapy on mortality among HIV-positive children and adolescents in China

The care status and factors affecting antiretroviral therapy timing for people living with HIV: a retrospective cohort study in Shandong Province, China